Uptake of Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in a Single Clinical Commissioning Group in England Without Restrictions to Their Use-Reference-Cited by-同舟云学术

Uptake of Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in a Single Clinical Commissioning Group in England Without Restrictions to Their Use

Published:2019-02-25 Issue:4 Volume:39 Page:401-405
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Medlinskiene Kristina^ORCID,Fay Matthew,Petty Duncan

Funder

Bayer HealthCare

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s40261-019-00763-y/fulltext.html

Reference25 articles.

1. Lane DA, Skjoth F, Lip GYH, LarsenTB, Kotecha D. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc. 2017;6:e005155.

2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1999;22:983–8.

3. Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circulation Research. 2017;120:439–48.

4. Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age and Ageing. 2009;38:27–32.

5. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37:2893–962.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice of oral anticoagulant prescribed by general practices in Wales: Application of Dirichlet regression and linked data;British Journal of Clinical Pharmacology;2022-01-25

2. Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent;Drug Safety;2021-07-22